Back to Report Store Home

Antibacterial Therapies Drug Development Pipeline Review, 2017

  • Published: Mar-2017
  • Report Code: GBIHC004IDB
  • Report Format: pdf

Description

List of Tables

Number of Products under Development for Tuberculosis

Number of Products under Development for Tuberculosis – Comparative Analysis

Number of Products under Development for Community Acquired Pneumonia

Number of Products under Development for Hospital Acquired Pneumonia (HAP) – Comparative Analysis

Number of Products under Development for Hospital Acquired Pneumonia (HAP)

Number of Products under Development for Hospital Acquired Pneumonia (HAP) – Comparative Analysis

Number of Products under Development for Ventilator Associated Pneumonia (VAP)

Number of Products under Development for Ventilator Associated Pneumonia (VAP) – Comparative Analysis

Number of Products under Development for Pseudomonas aeruginosa Infections

Number of Products under Development for Pseudomonas aeruginosa Infections – Comparative Analysis

Number of Products under Development for Klebsiella pneumoniae Infections

Number of Products under Development for Klebsiella pneumoniae Infections – Comparative Analysis

Number of Products under Development for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Number of Products under Development for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Comparative Analysis

Number of Products under Development for Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Number of Products under Development for Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Number of Products under Development for Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Comparative Analysis

Number of Products under Development by Companies, Tuberculosis

Number of Products under Development by Companies, Community Acquired Pneumonia

Number of Products under Development by Companies, Hospital Acquired Pneumonia (HAP)

Number of Products under Development by Companies, Ventilator Associated Pneumonia (VAP)

Number of Products under Development by Companies, Pseudomonas aeruginosa Infections

Number of Products under Development by Companies, Klebsiella pneumoniae Infections

Number of Products under Development by Companies, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Number of Products under Development by Companies, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Number of Products under Development by Companies, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Number of Products under Investigation by Universities/Institutes, Tuberculosis

Number of Products under Investigation by Universities/Institutes, Hospital Acquired Pneumonia (HAP)

Number of Products under Investigation by Universities/Institutes, Ventilator Associated Pneumonia (VAP)

Number of Products under Investigation by Universities/Institutes, Pseudomonas aeruginosa Infections

Number of Products under Investigation by Universities/Institutes, Klebsiella pneumoniae Infections

Number of Products under Investigation by Universities/Institutes, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Number of Products under Investigation by Universities/Institutes, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Comparative Analysis by Late Stage Development, Tuberculosis

Comparative Analysis by Clinical Stage Development, Tuberculosis

Comparative Analysis by Early Stage Development, Tuberculosis

Comparative Analysis by Unknown Stage Development, Tuberculosis

Comparative Analysis by Late Stage Development, Community Acquired Pneumonia

Comparative Analysis by Clinical Stage Development, Community Acquired Pneumonia

Comparative Analysis by Early Stage Development, Community Acquired Pneumonia

Comparative Analysis by Late Stage Development, Hospital Acquired Pneumonia (HAP)

Comparative Analysis by Clinical Stage Development, Hospital Acquired Pneumonia (HAP)

Comparative Analysis by Early Stage Development, Hospital Acquired Pneumonia (HAP)

Comparative Analysis by Unknown Stage Development, Hospital Acquired Pneumonia (HAP)

Comparative Analysis by Late Stage Development, Ventilator Associated Pneumonia (VAP)

Comparative Analysis by Clinical Stage Development, Ventilator Associated Pneumonia (VAP)

Comparative Analysis by Early Stage Development, Ventilator Associated Pneumonia (VAP)

Comparative Analysis by Unknown Stage Development, Ventilator Associated Pneumonia (VAP)

Comparative Analysis by Late Stage Development, Pseudomonas aeruginosa Infections

Comparative Analysis by Clinical Stage Development, Pseudomonas aeruginosa Infections

Comparative Analysis by Early Stage Development, Pseudomonas aeruginosa Infections

Comparative Analysis by Unknown Stage Development, Pseudomonas aeruginosa Infections

Comparative Analysis by Late Stage Development, Klebsiella pneumoniae Infections

Comparative Analysis by Clinical Stage Development, Klebsiella pneumoniae Infections

Comparative Analysis by Early Stage Development, Klebsiella pneumoniae Infections

Comparative Analysis by Late Stage Development, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Comparative Analysis by Clinical Stage Development, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Comparative Analysis by Early Stage Development, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Comparative Analysis by Unknown Stage Development, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Comparative Analysis by Clinical Stage Development, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Comparative Analysis by Early Stage Development, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Comparative Analysis by Clinical Stage Development, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Comparative Analysis by Early Stage Development, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Products under Development by Companies, Tuberculosis

Products under Development by Companies, Community Acquired Pneumonia

Products under Development by Companies, Hospital Acquired Pneumonia (HAP)

Products under Development by Companies, Ventilator Associated Pneumonia (VAP)

Products under Development by Companies, Pseudomonas aeruginosa Infections

Products under Development by Companies, Klebsiella pneumoniae Infections

Products under Development by Companies, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Products under Development by Companies, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Products under Development by Companies, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Products under Investigation by Universities/Institutes, Tuberculosis

Products under Investigation by Universities/Institutes, Hospital Acquired Pneumonia (HAP)

Products under Investigation by Universities/Institutes, Ventilator Associated Pneumonia (VAP)

Products under Investigation by Universities/Institutes, Pseudomonas aeruginosa Infections

Products under Investigation by Universities/Institutes, Klebsiella pneumoniae Infections

Products under Investigation by Universities/Institutes, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Products under Investigation by Universities/Institutes, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Tuberculosis – Pipeline by Abera Bioscience AB,

Tuberculosis – Pipeline by Akthelia Pharmaceuticals Limited,

Tuberculosis – Pipeline by Alvogen Korea Co., Ltd.,

Tuberculosis – Pipeline by Anacor Pharmaceuticals, Inc.,

Tuberculosis – Pipeline by Archivel Farma S.L.,

Tuberculosis – Pipeline by AstraZeneca Plc,

Tuberculosis – Pipeline by Beech Tree Labs, Inc.,

Tuberculosis – Pipeline by BioDiem Ltd,

Tuberculosis – Pipeline by BioLingus AG,

Tuberculosis – Pipeline by Biomar Microbial Technologies,

Tuberculosis – Pipeline by Bioversys AG,

Tuberculosis – Pipeline by Celgene Corporation,

Tuberculosis – Pipeline by Cellceutix Corporation,

Tuberculosis – Pipeline by Chongqing Zhifei Biological Products Co., Ltd.,

Tuberculosis – Pipeline by Crestone, Inc.,

Tuberculosis – Pipeline by Dafra Pharma International Ltd.,

Tuberculosis – Pipeline by Daiichi Sankyo Company, Limited,

Tuberculosis – Pipeline by Demuris Limited,

Tuberculosis – Pipeline by Eisai Co., Ltd.,

Tuberculosis – Pipeline by Eli Lilly and Company,

Tuberculosis – Pipeline by Ensol Biosciences Inc.,

Tuberculosis – Pipeline by EpiVax, Inc.,

Tuberculosis – Pipeline by FIT Biotech Oy,

Tuberculosis – Pipeline by GangaGen Inc.,

Tuberculosis – Pipeline by GlaxoSmithKline Plc,

Tuberculosis – Pipeline by Globeimmune, Inc.,

Tuberculosis – Pipeline by Hager Biosciences, LLC,

Tuberculosis – Pipeline by Hsiri Therapeutics LLC,

Tuberculosis – Pipeline by Imaxio SA,

Tuberculosis – Pipeline by Immunitor, Inc.,

Tuberculosis – Pipeline by ImmunoBiology Limited,

Tuberculosis – Pipeline by Inovio Pharmaceuticals, Inc.,

Tuberculosis – Pipeline by Johnson & Johnson,

Tuberculosis – Pipeline by Lakewood-Amedex Inc,

Tuberculosis – Pipeline by Lipotek Pty Ltd.,

Tuberculosis – Pipeline by Matinas BioPharma Holdings, Inc.

Tuberculosis – Pipeline by Microbion Corporation,

Tuberculosis – Pipeline by Microbiotix, Inc.,

Tuberculosis – Pipeline by NEARMEDIC PLUS, Ltd,

Tuberculosis – Pipeline by Novartis AG,

Tuberculosis – Pipeline by NovoBiotic Pharmaceuticals, LLC,

Tuberculosis – Pipeline by Otsuka Holdings Co., Ltd.,

Tuberculosis – Pipeline by QureTech Bio AB,

Tuberculosis – Pipeline by Recce Pty Ltd,

Tuberculosis – Pipeline by Rodos BioTarget GmbH,

Tuberculosis – Pipeline by Sanofi,

Tuberculosis – Pipeline by Sanofi Pasteur SA,

Tuberculosis – Pipeline by Sarepta Therapeutics, Inc.,

Tuberculosis – Pipeline by Sequella, Inc.,

Tuberculosis – Pipeline by Shionogi & Co., Ltd.,

Tuberculosis – Pipeline by Sphaera Pharma Pvt. Ltd.,

Tuberculosis – Pipeline by Spring Bank Pharmaceuticals, Inc.,

Tuberculosis – Pipeline by Takeda Pharmaceutical Company Limited,

Tuberculosis – Pipeline by TetraLogic Pharmaceuticals,

Tuberculosis – Pipeline by TGV-Laboratories,

Tuberculosis – Pipeline by Theravectys SA,

Tuberculosis – Pipeline by Tomegavax, Inc.,

Tuberculosis – Pipeline by Transgene SA,

Tuberculosis – Pipeline by TVAX Biomedical, Inc.,

Tuberculosis – Pipeline by Univalue Valorizacion, S.L.,

Tuberculosis – Pipeline by Vaccibody AS,

Tuberculosis – Pipeline by Vakzine Projekt Management GmbH,

Tuberculosis – Pipeline by Vaxil Bio Therapeutics Ltd.,

Tuberculosis – Pipeline by Vichem Chemie Research Ltd.,

Community Acquired Pneumonia – Pipeline by Aridis Pharmaceuticals LLC,

Community Acquired Pneumonia – Pipeline by BioAegis Therapeutics, Inc.,

Community Acquired Pneumonia – Pipeline by Biotest AG,

Community Acquired Pneumonia – Pipeline by C10 Pharma AS,

Community Acquired Pneumonia – Pipeline by InflaRx GmbH,

Community Acquired Pneumonia – Pipeline by ioGenetics, Inc.,

Community Acquired Pneumonia – Pipeline by Kyorin Pharmaceutical Co., Ltd.,

Community Acquired Pneumonia – Pipeline by Lascco SA,

Community Acquired Pneumonia – Pipeline by Melinta Therapeutics, Inc,

Community Acquired Pneumonia – Pipeline by Merck & Co., Inc.,

Community Acquired Pneumonia – Pipeline by Nabriva Therapeutics AG,

Community Acquired Pneumonia – Pipeline by Paratek Pharmaceuticals, Inc.,

Community Acquired Pneumonia – Pipeline by TaiGen Biotechnology Co., Ltd.,

Community Acquired Pneumonia – Pipeline by Takeda Pharmaceutical Company Limited,

Community Acquired Pneumonia – Pipeline by Tetraphase Pharmaceuticals Inc.,

Community Acquired Pneumonia – Pipeline by TiGenix NV,

Hospital Acquired Pneumonia (HAP) – Pipeline by Achaogen Inc.,

Hospital Acquired Pneumonia (HAP) – Pipeline by Adenium Biotech ApS,

Hospital Acquired Pneumonia (HAP) – Pipeline by Aridis Pharmaceuticals LLC,

Hospital Acquired Pneumonia (HAP) – Pipeline by AstraZeneca Plc,

Hospital Acquired Pneumonia (HAP) – Pipeline by Bayer AG,

Hospital Acquired Pneumonia (HAP) – Pipeline by Cardeas Pharma Corp.,

Hospital Acquired Pneumonia (HAP) – Pipeline by MedImmune, LLC,

Hospital Acquired Pneumonia (HAP) – Pipeline by Meiji Seika Pharma Co., Ltd.,

Hospital Acquired Pneumonia (HAP) – Pipeline by Melinta Therapeutics, Inc,

Hospital Acquired Pneumonia (HAP) – Pipeline by Merck & Co., Inc.,

Hospital Acquired Pneumonia (HAP) – Pipeline by Motif Bio Plc,

Hospital Acquired Pneumonia (HAP) – Pipeline by Nabriva Therapeutics AG,

Hospital Acquired Pneumonia (HAP) – Pipeline by Savara Inc.,

Hospital Acquired Pneumonia (HAP) – Pipeline by Sealife PHARMA GMBH,

Hospital Acquired Pneumonia (HAP) – Pipeline by Shionogi & Co., Ltd.,

Hospital Acquired Pneumonia (HAP) – Pipeline by Tetraphase Pharmaceuticals Inc.,

Hospital Acquired Pneumonia (HAP) – Pipeline by Wockhardt Limited,

Hospital Acquired Pneumonia (HAP) – Pipeline by Zavante Therapeutics, Inc.,

Ventilator Associated Pneumonia (VAP) – Pipeline by Achaogen Inc.,

Ventilator Associated Pneumonia (VAP) – Pipeline by Adenium Biotech ApS,

Ventilator Associated Pneumonia (VAP) – Pipeline by Aridis Pharmaceuticals LLC,

Ventilator Associated Pneumonia (VAP) – Pipeline by AstraZeneca Plc,

Ventilator Associated Pneumonia (VAP) – Pipeline by Bayer AG,

Ventilator Associated Pneumonia (VAP) – Pipeline by Cardeas Pharma Corp.,

Ventilator Associated Pneumonia (VAP) – Pipeline by MedImmune, LLC,

Ventilator Associated Pneumonia (VAP) – Pipeline by Meiji Seika Pharma Co., Ltd.,

Ventilator Associated Pneumonia (VAP) – Pipeline by Merck & Co., Inc.,

Ventilator Associated Pneumonia (VAP) – Pipeline by Motif Bio Plc,

Ventilator Associated Pneumonia (VAP) – Pipeline by Nabriva Therapeutics AG,

Ventilator Associated Pneumonia (VAP) – Pipeline by Savara Inc.,

Ventilator Associated Pneumonia (VAP) – Pipeline by Shionogi & Co., Ltd.,

Ventilator Associated Pneumonia (VAP) – Pipeline by Tetraphase Pharmaceuticals Inc.,

Ventilator Associated Pneumonia (VAP) – Pipeline by Zavante Therapeutics, Inc.,

Pseudomonas aeruginosa Infections – Pipeline by Achaogen Inc,

Pseudomonas aeruginosa Infections – Pipeline by Adenium Biotech ApS,

Pseudomonas aeruginosa Infections – Pipeline by Aeolus Pharmaceuticals Inc,

Pseudomonas aeruginosa Infections – Pipeline by AlgiPharma AS,

Pseudomonas aeruginosa Infections – Pipeline by AmpliPhi Biosciences Corp,

Pseudomonas aeruginosa Infections – Pipeline by AnGes MG Inc,

Pseudomonas aeruginosa Infections – Pipeline by Arch Biopartners, Inc.,

Pseudomonas aeruginosa Infections – Pipeline by Aridis Pharmaceuticals LLC,

Pseudomonas aeruginosa Infections – Pipeline by Arno Therapeutics Inc,

Pseudomonas aeruginosa Infections – Pipeline by AstraZeneca Plc,

Pseudomonas aeruginosa Infections – Pipeline by Biolytics Pharma,

Pseudomonas aeruginosa Infections – Pipeline by Catabasis Pharmaceuticals Inc,

Pseudomonas aeruginosa Infections – Pipeline by Cellceutix Corp,

Pseudomonas aeruginosa Infections – Pipeline by CSA Biotechnologies LLC,

Pseudomonas aeruginosa Infections – Pipeline by Cyclacel Pharmaceuticals Inc,

Pseudomonas aeruginosa Infections – Pipeline by Evaxion Biotech ApS,

Pseudomonas aeruginosa Infections – Pipeline by F. Hoffmann-La Roche Ltd,

Pseudomonas aeruginosa Infections – Pipeline by FOB Synthesis Inc,

Pseudomonas aeruginosa Infections – Pipeline by GlaxoSmithKline Plc,

Pseudomonas aeruginosa Infections – Pipeline by Helix BioMedix Inc,

Pseudomonas aeruginosa Infections – Pipeline by Hsiri Therapeutics LLC,

Pseudomonas aeruginosa Infections – Pipeline by Immun System IMS AB,

Pseudomonas aeruginosa Infections – Pipeline by Insmed Inc,

Pseudomonas aeruginosa Infections – Pipeline by Lascco SA,

Pseudomonas aeruginosa Infections – Pipeline by Laurent Pharmaceuticals Inc,

Pseudomonas aeruginosa Infections – Pipeline by LegoChem Biosciences Inc,

Pseudomonas aeruginosa Infections – Pipeline by Lytix Biopharma AS,

Pseudomonas aeruginosa Infections – Pipeline by MedImmune LLC,

Pseudomonas aeruginosa Infections – Pipeline by Melinta Therapeutics Inc,

Pseudomonas aeruginosa Infections – Pipeline by Microbiotix Inc,

Pseudomonas aeruginosa Infections – Pipeline by Nosopharm SAS,

Pseudomonas aeruginosa Infections – Pipeline by Novabiotics Ltd,

Pseudomonas aeruginosa Infections – Pipeline by Omnia Molecular Ltd,

Pseudomonas aeruginosa Infections – Pipeline by Peptilogics Inc,

Pseudomonas aeruginosa Infections – Pipeline by Pfizer Inc,

Pseudomonas aeruginosa Infections – Pipeline by Pherecydes Pharma SA,

Pseudomonas aeruginosa Infections – Pipeline by Phico Therapeutics Ltd,

Pseudomonas aeruginosa Infections – Pipeline by Polyphor Ltd,

Pseudomonas aeruginosa Infections – Pipeline by Procarta Biosystems Ltd,

Pseudomonas aeruginosa Infections – Pipeline by Sanofi,

Pseudomonas aeruginosa Infections – Pipeline by Sarepta Therapeutics Inc,

Pseudomonas aeruginosa Infections – Pipeline by Sealife PHARMA GMBH,

Pseudomonas aeruginosa Infections – Pipeline by Sequoia Sciences Inc,

Pseudomonas aeruginosa Infections – Pipeline by Shionogi & Co Ltd,

Pseudomonas aeruginosa Infections – Pipeline by Soligenix Inc,

Pseudomonas aeruginosa Infections – Pipeline by Syntiron LLC,

Pseudomonas aeruginosa Infections – Pipeline by Tetraphase Pharmaceuticals Inc,

Pseudomonas aeruginosa Infections – Pipeline by Varinel Inc,

Pseudomonas aeruginosa Infections – Pipeline by Vaxdyn SL,

Pseudomonas aeruginosa Infections – Pipeline by Zambon Company SpA,

Klebsiella pneumoniae Infections – Pipeline by Appili Therapeutics Inc,

Klebsiella pneumoniae Infections – Pipeline by Arsanis, Inc.,

Klebsiella pneumoniae Infections – Pipeline by Cellceutix Corporation,

Klebsiella pneumoniae Infections – Pipeline by Debiopharm International SA ,

Klebsiella pneumoniae Infections – Pipeline by Evaxion Biotech ApS,

Klebsiella pneumoniae Infections – Pipeline by F. Hoffmann-La Roche Ltd.,

Klebsiella pneumoniae Infections – Pipeline by FOB Synthesis, Inc.,

Klebsiella pneumoniae Infections – Pipeline by Melinta Therapeutics, Inc,

Klebsiella pneumoniae Infections – Pipeline by Merck & Co., Inc.,

Klebsiella pneumoniae Infections – Pipeline by MicuRx Pharmaceuticals, Inc.,

Klebsiella pneumoniae Infections – Pipeline by Nosopharm SAS,

Klebsiella pneumoniae Infections – Pipeline by Peptilogics, Inc.,

Klebsiella pneumoniae Infections – Pipeline by Pfizer Inc.,

Klebsiella pneumoniae Infections – Pipeline by Phico Therapeutics Limited,

Klebsiella pneumoniae Infections – Pipeline by Procarta Biosystems Limited,

Klebsiella pneumoniae Infections – Pipeline by Sarepta Therapeutics, Inc.,

Klebsiella pneumoniae Infections – Pipeline by Shionogi & Co., Ltd.,

Klebsiella pneumoniae Infections – Pipeline by Soligenix, Inc.,

Klebsiella pneumoniae Infections – Pipeline by Sumitomo Dainippon Pharma Co., Ltd.,

Klebsiella pneumoniae Infections – Pipeline by Syntiron LLC,

Klebsiella pneumoniae Infections – Pipeline by Tetraphase Pharmaceuticals Inc.,

Klebsiella pneumoniae Infections – Pipeline by Varinel, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Absynth Biologics Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Actelion Ltd,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Adenium Biotech ApS,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AIMM Therapeutics B.V.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Alchemia Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Allergan Plc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AlphaMab Co., Ltd,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Alvogen Korea Co., Ltd.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AmpliPhi Biosciences Corporation,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AnGes MG, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Antibiotx ApS,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Aphios Corporation,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Aridis Pharmaceuticals LLC,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Arsanis, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AstraZeneca Plc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Atriva Therapeutics GmbH,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Bavarian Nordic A/S,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Bharat Biotech International Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by C3 Jian, Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Cellceutix Corporation,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Cempra Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Citius Pharmaceuticals, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Common Pharma Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by ContraFect Corporation,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Crestone, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Critical Outcome Technologies Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by CrystalGenomics, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by CSA Biotechnologies LLC ,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Debiopharm International SA ,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Dermala Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by DesignMedix, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Destiny Pharma Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Dong-A Socio Holdings Co. Ltd.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by e-Therapeutics Plc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Emergent BioSolutions Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Ensol Biosciences Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Excelimmune, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Galapagos NV,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by GangaGen Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Gero Corp,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Helix BioMedix, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Hsiri Therapeutics LLC,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Ildong Pharmaceutical Co., Ltd.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Immupharma Plc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by iNtRON Biotechnology Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by ioGenetics, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Kyorin Pharmaceutical Co., Ltd.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Lascco SA,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by LegoChem Biosciences, Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Lipocure Ltd.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Madam Therapeutics B.V.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Melinta Therapeutics, Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Merck & Co., Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Microbiotix, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by MicuRx Pharmaceuticals, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by MorphoSys AG,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Motif Bio Plc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Nabriva Therapeutics AG,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Nemus Bioscience, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Novabiotics Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by NovaDigm Therapeutics, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by NovoBiotic Pharmaceuticals, LLC,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Omnia Molecular Ltd.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Oragenics, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Pfizer Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Phico Therapeutics Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Procarta Biosystems Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Prommune, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Recce Pty Ltd,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Redx Pharma Plc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sarepta Therapeutics, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Savara Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sealife PHARMA GMBH,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sentinella Pharmaceuticals, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sequoia Sciences Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Soligenix, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sorrento Therapeutics Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Taejoon Pharm Co., Ltd.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by TAXIS Pharmaceuticals, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Telephus Medical LLC,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Tetraphase Pharmaceuticals Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by TGV-Laboratories,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Theravance Biopharma Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Trellis Bioscience, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Valevia UK Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by VLP Biotech, Inc.,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Wintermute Biomedical LLC,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Wockhardt Limited,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by XBiotech Inc,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Yungjin Pharm. Co., Ltd.,

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections – Pipeline by Allergan Plc,

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections – Pipeline by Galapagos NV,

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections – Pipeline by Merck & Co Inc,

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections – Pipeline by Syntiron LLC,

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections – Pipeline by Valevia UK Ltd,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Pipeline by Destiny Pharma Ltd,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Pipeline by Galapagos NV,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Pipeline by MGB Biopharma Ltd,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Pipeline by Syntiron LLC,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Pipeline by Techulon Inc,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Pipeline by Valevia UK Ltd,

Assessment by Monotherapy Products, Tuberculosis

Assessment by Combination Products, Tuberculosis

Number of Products by Stage and Target, Tuberculosis

Number of Products by Stage and Mechanism of Action, Tuberculosis

Number of Products by Stage and Route of Administration, Tuberculosis

Number of Products by Stage and Molecule Type, Tuberculosis

Assessment by Monotherapy Products, Community Acquired Pneumonia

Number of Products by Stage and Target, Community Acquired Pneumonia

Number of Products by Stage and Mechanism of Action, Community Acquired Pneumonia

Number of Products by Stage and Route of Administration, Community Acquired Pneumonia

Number of Products by Stage and Molecule Type, Community Acquired Pneumonia

Assessment by Monotherapy Products, Hospital Acquired Pneumonia (HAP)

Assessment by Combination Products, Hospital Acquired Pneumonia (HAP)

Number of Products by Stage and Target, Hospital Acquired Pneumonia (HAP)

Number of Products by Stage and Mechanism of Action, Hospital Acquired Pneumonia (HAP)

Number of Products by Stage and Route of Administration, Hospital Acquired Pneumonia (HAP)

Number of Products by Stage and Molecule Type, Hospital Acquired Pneumonia (HAP)

Assessment by Monotherapy Products, Ventilator Associated Pneumonia (VAP)

Assessment by Combination Products, Ventilator Associated Pneumonia (VAP)

Number of Products by Stage and Target, Ventilator Associated Pneumonia (VAP)

Number of Products by Stage and Mechanism of Action, Ventilator Associated Pneumonia (VAP)

Number of Products by Stage and Route of Administration, Ventilator Associated Pneumonia (VAP)

Number of Products by Stage and Molecule Type, Ventilator Associated Pneumonia (VAP)

Assessment by Monotherapy Products, Pseudomonas aeruginosa Infections

Assessment by Combination Products, Pseudomonas aeruginosa Infections

Number of Products by Stage and Target, Pseudomonas aeruginosa Infections

Number of Products by Stage and Mechanism of Action, Pseudomonas aeruginosa Infections

Number of Products by Stage and Route of Administration, Pseudomonas aeruginosa Infections

Number of Products by Stage and Molecule Type, Pseudomonas aeruginosa Infections

Assessment by Monotherapy Products, Klebsiella pneumoniae Infections

Number of Products by Stage and Target, Klebsiella pneumoniae Infections

Number of Products by Stage and Mechanism of Action, Klebsiella pneumoniae Infections

Number of Products by Stage and Route of Administration, Klebsiella pneumoniae Infections

Number of Products by Stage and Molecule Type, Klebsiella pneumoniae Infections

Assessment by Monotherapy Products, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Assessment by Combination Products, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Number of Products by Stage and Target, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Number of Products by Stage and Mechanism of Action, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Number of Products by Stage and Route of Administration, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Number of Products by Stage and Molecule Type, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Assessment by Monotherapy Products, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Number of Products by Stage and Target, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Number of Products by Stage and Mechanism of Action, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Number of Products by Stage and Route of Administration, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Number of Products by Stage and Molecule Type, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections

Assessment by Monotherapy Products, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Number of Products by Stage and Target, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Number of Products by Stage and Mechanism of Action, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Number of Products by Stage and Route of Administration, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Number of Products by Stage and Molecule Type, Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections

Tuberculosis – Dormant Projects,

Community Acquired Pneumonia – Dormant Projects,

Hospital Acquired Pneumonia (HAP) – Dormant Projects,

Ventilator Associated Pneumonia (VAP) – Dormant Projects,

Pseudomonas aeruginosa Infections – Dormant Projects,

Klebsiella pneumoniae Infections – Dormant Projects,

Klebsiella pneumoniae Infections – Dormant Projects (Contd..1),

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects,

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections – Dormant Projects,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Dormant Projects,

Tuberculosis – Discontinued Products,

Community Acquired Pneumonia – Discontinued Products,

Hospital Acquired Pneumonia (HAP) – Discontinued Products,

Ventilator Associated Pneumonia (VAP) – Discontinued Products,

Pseudomonas aeruginosa Infections – Discontinued Products,

Klebsiella pneumoniae Infections – Discontinued Products,

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Discontinued Products,

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections – Discontinued Products

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5817
Or click here to contact us
Secure Payments
Cards